Moderna Some Approvals Ahead: Is the Stock a Buy?
Moderna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Compare tax costs between dividend ETFs and mutual funds to determine which option generally incurs higher or lower taxes in real scenarios.
28,480 articlesModerna’s growth story now centers on a broader mRNA pipeline and FDA decisions. This guide breaks down the upcoming ...
Global policymakers wrestle with ai sovereignty as the economy and everyday life increasingly rely on frontier AI. Th...
Meta Platforms is negotiating a landmark AI hardware pact with AMD that could top $100 billion, including an option f...
Netflix’s ad-supported tier is gaining traction and subscribers are rising, even as the broader market spurs a debate...
Advance Auto Parts and Monro report stabilizing results. AAP signals margin expansion; Monro confronts guidance uncer...
Investors are weighing Plug Power's turnaround against hydrogen hype. This guide breaks down the signals, risks, and ...
Geopolitical tensions around Iran are pushing oil volatility and, in turn, accelerating EV adoption. Analysts warn th...
A big set of economic moves is at play: jobs data, inflation, and housing trends. This guide explains how nearly mill...
OpenAI confronts multi-front pressure as its largest backer rethinks bets, Microsoft shifts workloads inward, and riv...
Palantir’s stock dropped third from its peak as investor Michael Burry reveals a new critique centered on the company...
Analysts warn that Iran could use control of key internet cables as a new economic lever, risking a wave of volatilit...
June 2026 opens with a handful of beaten-down stocks that could roar back as inflation cools and earnings beat expect...